Close Menu

drug abuse

Prescient will further the development and commercialization of the Infiniti Neural Response Panel to identify patients who may be at risk for opioid use disorder.

An epigenome-wide association study in women with opioid dependence led to hypomethylated sites in three genes involved in various cellular processes.

After a series of duplication and rearrangement events, the genes involved in two key pathways producing morphine, codeine, and noscapine have clustered in the genome.

The university is marshaling the expertise across all its schools in studying myriad factors that might contribute to opioid response, addiction, and abuse.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

The clinical trial is designed to validate that biomarkers, measured in routine urine tests, effectively predict genetic mutations in drug-metabolizing enzymes.

A genome-wide association study of participants from three substance dependence cohorts led to variants in some of the same genes linked to psychiatric disease.

BioRealm SmokeScreen Genotyping Array Looks to Boost Drug Addiction Research

The bespoke array, designed in tandem with Affymetrix, has nearly 650,000 markers to look at genes associated with addiction in several population groups.

NEW YORK (GenomeWeb) – The University of Chicago said on Thursday it has been awarded a five-year, $12 million grant from the National Institute on Drug Abuse to create a center of excellence using rats to study the genetics of drug abuse.

NEW YORK (GenomeWeb News) – The National Institutes of Health is planning to fund research into the genetic and epigenetic factors that may promote alcohol and drug co-addiction, according to a funding announcement published this week.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.